FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

1852611000001100: Cilest 250microgram / 35microgram tablets (Janssen-Cilag Ltd) 126 tablet 6 x 21 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25065501000001116 Cilest 250microgram / 35microgram tablets (Janssen-Cilag Ltd) 126 tablet 6 x 21 tablets (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
93210401000001115 Cilest 35microgram/250microgram tablets (Janssen-Cilag Ltd) 126 tablet 6 x 21 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cilest 250microgram / 35microgram tablets (Janssen-Cilag Ltd) 126 tablet 6 x 21 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (Janssen-Cilag Ltd) 126 tablet 6 x 21 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (Janssen-Cilag Ltd) 126 tablet 6 x 21 tablets Is a Norgestimate 250microgram / Ethinylestradiol 35microgram tablets 126 tablet true Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (Janssen-Cilag Ltd) 126 tablet 6 x 21 tablets Is pack of Cilest 250microgram / 35microgram tablets (Janssen-Cilag Ltd) false Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (Janssen-Cilag Ltd) 126 tablet 6 x 21 tablets Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (Janssen-Cilag Ltd) 126 tablet 6 x 21 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (Janssen-Cilag Ltd) 126 tablet 6 x 21 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (Janssen-Cilag Ltd) 126 tablet 6 x 21 tablets Has active ingredient Progesterone false Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (Janssen-Cilag Ltd) 126 tablet 6 x 21 tablets Has active ingredient Ethinylestradiol false Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (Janssen-Cilag Ltd) 126 tablet 6 x 21 tablets Has active ingredient Norgestimate false Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (Janssen-Cilag Ltd) 126 tablet 6 x 21 tablets Has active ingredient Synthetic progestogen false Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (Janssen-Cilag Ltd) 126 tablet 6 x 21 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (Janssen-Cilag Ltd) 126 tablet 6 x 21 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (Janssen-Cilag Ltd) 126 tablet 6 x 21 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (Janssen-Cilag Ltd) 126 tablet 6 x 21 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (Janssen-Cilag Ltd) 126 tablet 6 x 21 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (Janssen-Cilag Ltd) 126 tablet 6 x 21 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (Janssen-Cilag Ltd) 126 tablet 6 x 21 tablets Has AMP Cilest 250microgram / 35microgram tablets (Janssen-Cilag Ltd) true Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (Janssen-Cilag Ltd) 126 tablet 6 x 21 tablets Has specific active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (Janssen-Cilag Ltd) 126 tablet 6 x 21 tablets Has specific active ingredient Norgestimate true Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (Janssen-Cilag Ltd) 126 tablet 6 x 21 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (Janssen-Cilag Ltd) 126 tablet 6 x 21 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (Janssen-Cilag Ltd) 126 tablet 6 x 21 tablets Discontinued indicator Discontinued AMPP(qualifier value) false Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (Janssen-Cilag Ltd) 126 tablet 6 x 21 tablets Discontinued indicator Re-marketed false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start